Position in ABOS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$487,771
+$239,107 QoQ
Shares Held
206,683
+75.4% QoQ
Ownership
0.286%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 84 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ABOS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,297,038,010 across 364 Biotechnology names. ABOS ranks #290 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in ABOS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $487,771 | 206,683 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $248,664 | 117,851 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $251,622 | 147,148 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $388,231 | 334,683 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $215,827 | 196,207 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $376,927 | 219,144 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $361,734 | 145,861 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $123,545 | 51,052 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,287,511 | 317,904 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $440,570 | 114,732 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $237,790 | 57,299 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $65,281 | 13,572 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $171,746 | 42,302 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $91,751 | 16,991 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $226,848 | 22,617 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $131,064 | 27,886 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $1,306,702 | 334,195 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,185,264 | 323,264 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $945,616 | 63,635 | Shares | Defined | 2022-01-20 | |
| No filing history on record for this holder in this stock. | ||||||